{
  "DOI": "10.1007/s00439-018-1944-6",
  "ISSN": [
    "0340-6717",
    "1432-1203"
  ],
  "URL": "http://dx.doi.org/10.1007/s00439-018-1944-6",
  "alternative-id": [
    "1944"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "1 June 2018"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "11 October 2018"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "17 October 2018"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The author declares that they have no conflict of interest."
    },
    {
      "group": {
        "label": "Ethical approval",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards."
    },
    {
      "group": {
        "label": "Informed consent",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "For this type of study, formal consent is not required."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Narod",
      "given": "Steven A.",
      "sequence": "first"
    }
  ],
  "container-title": [
    "Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2018,
        10,
        17
      ]
    ],
    "date-time": "2018-10-17T08:22:24Z",
    "timestamp": 1539764544000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        10,
        16
      ]
    ],
    "date-time": "2019-10-16T23:15:44Z",
    "timestamp": 1571267744000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        22
      ]
    ],
    "date-time": "2024-03-22T14:59:43Z",
    "timestamp": 1711119583448
  },
  "is-referenced-by-count": 32,
  "issn-type": [
    {
      "type": "print",
      "value": "0340-6717"
    },
    {
      "type": "electronic",
      "value": "1432-1203"
    }
  ],
  "issue": "10",
  "issued": {
    "date-parts": [
      [
        2018,
        10
      ]
    ]
  },
  "journal-issue": {
    "issue": "10",
    "published-print": {
      "date-parts": [
        [
          2018,
          10
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2018,
            10,
            1
          ]
        ],
        "date-time": "2018-10-01T00:00:00Z",
        "timestamp": 1538352000000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/article/10.1007/s00439-018-1944-6/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s00439-018-1944-6.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s00439-018-1944-6.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "769-778",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2018,
        10
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2018,
        10,
        17
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2018,
        10
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.3747/co.24.3828",
      "author": "MR Akbari",
      "doi-asserted-by": "publisher",
      "first-page": "282",
      "journal-title": "Curr Oncol",
      "key": "1944_CR1",
      "unstructured": "Akbari MR, Gojska N, Narod SA (2017) Coming of age in Canada: a study of population-based genetic testing for breast and ovarian cancer. Curr Oncol 24:282–283",
      "volume": "24",
      "year": "2017"
    },
    {
      "DOI": "10.1016/S1470-2045(13)70611-9",
      "author": "F André",
      "doi-asserted-by": "publisher",
      "first-page": "267",
      "journal-title": "Lancet Oncol",
      "key": "1944_CR2",
      "unstructured": "André F, Bachelot T, Commo F et al (2014) Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER). Lancet Oncol 15:267–274",
      "volume": "15",
      "year": "2014"
    },
    {
      "DOI": "10.1016/S0140-6736(05)62601-3",
      "author": "M Baum",
      "doi-asserted-by": "publisher",
      "first-page": "810",
      "journal-title": "Lancet",
      "key": "1944_CR3",
      "unstructured": "Baum M (1997) Rethink on screening for breast cancer. Lancet 350:810–811",
      "volume": "350",
      "year": "1997"
    },
    {
      "DOI": "10.1056/NEJMp1401875",
      "author": "N Biller-Andorno",
      "doi-asserted-by": "publisher",
      "first-page": "1965",
      "journal-title": "N Engl J Med",
      "key": "1944_CR4",
      "unstructured": "Biller-Andorno N, Jüni P (2014) Abolishing mammography screening programs? A view from the Swiss Medical Board. N Engl J Med 370:1965–1967",
      "volume": "370",
      "year": "2014"
    },
    {
      "DOI": "10.1056/NEJMoa1206809",
      "author": "A Bleyer",
      "doi-asserted-by": "publisher",
      "first-page": "1998",
      "issue": "21",
      "journal-title": "N Engl J Med",
      "key": "1944_CR5",
      "unstructured": "Bleyer A, Welch HG (2012 Nov) Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 22(21):1998–2005 367(",
      "volume": "22",
      "year": "2012"
    },
    {
      "author": "W Burke",
      "key": "1944_CR6",
      "unstructured": "Burke W, Zimmern R (2007) Moving beyond ACCE. PHG Foundation, Cambridge",
      "volume-title": "Moving beyond ACCE",
      "year": "2007"
    },
    {
      "DOI": "10.1056/NEJMoa0801297",
      "author": "J Burn",
      "doi-asserted-by": "publisher",
      "first-page": "2567",
      "journal-title": "N Engl J Med",
      "key": "1944_CR7",
      "unstructured": "Burn J, Bishop DT, Mecklin JP, CAPP2 Investigators et al (2008) Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. N Engl J Med 359:2567–2578",
      "volume": "359",
      "year": "2008"
    },
    {
      "key": "1944_CR8",
      "unstructured": "Cancer Incidence in Five Continents (2002) IARC Scientific Publications, Lyon"
    },
    {
      "key": "1944_CR9",
      "unstructured": "CG001 Panel v2.3 HOTSPOT ANALYSIS [Internet]. Contextual Genomics, Vancouver (2016). \n                    http://contextualgenomics.com/wp-content/uploads/2016/02/CG001.v2.3_Cancer-Panel-1.pdf"
    },
    {
      "DOI": "10.1016/S0140-6736(08)60167-1",
      "author": "V Beral",
      "doi-asserted-by": "publisher",
      "first-page": "303",
      "journal-title": "Lancet",
      "key": "1944_CR10",
      "unstructured": "Collaborative Group on Epidemiological Studies of Ovarian Cancer, Beral V, Doll R et al (2008) Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet 371:303–314",
      "volume": "371",
      "year": "2008"
    },
    {
      "DOI": "10.1056/NEJMp1500523",
      "author": "FS Collins",
      "doi-asserted-by": "publisher",
      "first-page": "793",
      "journal-title": "N Engl J Med",
      "key": "1944_CR11",
      "unstructured": "Collins FS, Varmus H (2015) A new initiative on precision medicine. N Engl J Med 372:793–795",
      "volume": "372",
      "year": "2015"
    },
    {
      "DOI": "10.1016/S1470-2045(14)71171-4",
      "author": "J Cuzick",
      "doi-asserted-by": "publisher",
      "first-page": "67",
      "journal-title": "Lancet Oncol",
      "key": "1944_CR12",
      "unstructured": "Cuzick J, Sestak I, Cawthorn S et al (2015a) Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial. Lancet Oncol 16:67–75",
      "volume": "16",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.breast.2015.07.013",
      "author": "J Cuzick",
      "doi-asserted-by": "publisher",
      "journal-title": "Breast",
      "key": "1944_CR13",
      "unstructured": "Cuzick J, Sestak I, Thorat MA (2015b) Impact of preventive therapy on the risk of breast cancer among women with benign breast disease. Breast. \n                    https://doi.org/10.1016/j.breast.2015.07.013",
      "year": "2015"
    },
    {
      "DOI": "10.6004/jnccn.2017.0003",
      "author": "MB Daly",
      "doi-asserted-by": "publisher",
      "first-page": "9",
      "journal-title": "J Natl Compr Cancer Netw",
      "key": "1944_CR14",
      "unstructured": "Daly MB, Pilarski R, Berry M (2017) NCCN guidelines insights: genetic/familial high-risk assessment: breast and ovarian, version 2.2017. J Natl Compr Cancer Netw 15:9–20",
      "volume": "15",
      "year": "2017"
    },
    {
      "DOI": "10.1503/cmaj.171154",
      "author": "MJ Dobrow",
      "doi-asserted-by": "publisher",
      "first-page": "E422",
      "journal-title": "CMAJ",
      "key": "1944_CR15",
      "unstructured": "Dobrow MJ, Hagens V, Chafe R, Sullivan T, Rabeneck L. Consolidated principles for screening based on a systematic review and consensus process. CMAJ 2018;190:E422–E429",
      "volume": "190",
      "year": "2018"
    },
    {
      "DOI": "10.1038/nature05887",
      "author": "DF Easton",
      "doi-asserted-by": "publisher",
      "first-page": "1087",
      "journal-title": "Nature",
      "key": "1944_CR16",
      "unstructured": "Easton DF, Pooley KA, Dunning AM et al (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447:1087–1093",
      "volume": "447",
      "year": "2007"
    },
    {
      "DOI": "10.1111/cge.12313",
      "author": "A Finch",
      "doi-asserted-by": "publisher",
      "first-page": "496",
      "journal-title": "Clin Genet",
      "key": "1944_CR17",
      "unstructured": "Finch A, Bacopulos S, Rosen B et al (2014a) Preventing ovarian cancer through genetic testing: a population-based study. Clin Genet 86:496–499",
      "volume": "86",
      "year": "2014"
    },
    {
      "DOI": "10.1200/JCO.2013.53.2820",
      "author": "AP Finch",
      "doi-asserted-by": "publisher",
      "first-page": "1547",
      "journal-title": "J Clin Oncol",
      "key": "1944_CR18",
      "unstructured": "Finch AP, Lubinski J, Møller P et al (2014b) Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. J Clin Oncol 32:1547–1553",
      "volume": "32",
      "year": "2014"
    },
    {
      "DOI": "10.1093/jnci/90.18.1371",
      "author": "B Fisher",
      "doi-asserted-by": "publisher",
      "first-page": "1371",
      "journal-title": "J Natl Cancer Inst",
      "key": "1944_CR19",
      "unstructured": "Fisher B, Costantino JP, Wickerham DL et al (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90:1371–1388",
      "volume": "90",
      "year": "1998"
    },
    {
      "DOI": "10.1007/s10549-006-9261-5",
      "author": "J Gronwald",
      "doi-asserted-by": "publisher",
      "first-page": "239",
      "journal-title": "Breast Cancer Res Treat",
      "key": "1944_CR20",
      "unstructured": "Gronwald J, Huzarski T, Byrski T et al (2006a) Direct-to-patient BRCA1 testing: the Twoj Styl experience. Breast Cancer Res Treat 100:239–245",
      "volume": "100",
      "year": "2006"
    },
    {
      "DOI": "10.1002/ijc.21536",
      "author": "J Gronwald",
      "doi-asserted-by": "publisher",
      "first-page": "2281",
      "journal-title": "Int J Cancer",
      "key": "1944_CR21",
      "unstructured": "Gronwald J, Tung N, Foulkes WD et al (2006b) Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. Int J Cancer 118:2281–2284",
      "volume": "118",
      "year": "2006"
    },
    {
      "DOI": "10.1186/bcr3584",
      "author": "O Harismendy",
      "doi-asserted-by": "publisher",
      "first-page": "R115",
      "issue": "6",
      "journal-title": "Breast Cancer Res",
      "key": "1944_CR22",
      "unstructured": "Harismendy O, Schwab RB, Alakus H et al (2013) Evaluation of ultra-deep targeted sequencing for personalized breast cancer care. Breast Cancer Res 15(6):R115",
      "volume": "15",
      "year": "2013"
    },
    {
      "DOI": "10.1038/nrc2683",
      "author": "JM Hoskins",
      "doi-asserted-by": "publisher",
      "first-page": "576",
      "journal-title": "Nat Rev Cancer",
      "key": "1944_CR23",
      "unstructured": "Hoskins JM, Carey LA, McLeod HL (2009) CYP2D6 and tamoxifen: DNA matters in breast cancer. Nat Rev Cancer 9:576–586",
      "volume": "9",
      "year": "2009"
    },
    {
      "DOI": "10.1007/s10549-013-2823-4",
      "author": "J Kotsopoulos",
      "doi-asserted-by": "publisher",
      "first-page": "579",
      "journal-title": "Breast Cancer Res Treat",
      "key": "1944_CR24",
      "unstructured": "Kotsopoulos J, Lubinski J, Moller P, Hereditary Breast Cancer Clinical Study Group et al (2014) Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers. Breast Cancer Res Treat 143:579–586",
      "volume": "143",
      "year": "2014"
    },
    {
      "DOI": "10.1002/ijc.29386",
      "author": "J Kotsopoulos",
      "doi-asserted-by": "publisher",
      "first-page": "1136",
      "journal-title": "Int J Cancer",
      "key": "1944_CR25",
      "unstructured": "Kotsopoulos J, Lubinski J, Gronwald J et al (2015) Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. Int J Cancer 137:1136–1146",
      "volume": "137",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.ygyno.2018.05.011",
      "author": "J Kotsopoulos",
      "doi-asserted-by": "publisher",
      "first-page": "85",
      "journal-title": "Gynecol Oncol",
      "key": "1944_CR26",
      "unstructured": "Kotsopoulos J, Gronwald J, Karlan B, Hereditary Ovarian Cancer Clinical Study Group et al (2018) Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation. Gynecol Oncol 150:85–91",
      "volume": "150",
      "year": "2018"
    },
    {
      "DOI": "10.1038/nrg2516",
      "author": "P Kraft",
      "doi-asserted-by": "publisher",
      "first-page": "264",
      "journal-title": "Nat Rev Genet",
      "key": "1944_CR27",
      "unstructured": "Kraft P, Wacholder S, Cornelis MC et al (2009) Beyond odds ratios—communicating disease risk based on genetic profiles. Nat Rev Genet 10:264–269",
      "volume": "10",
      "year": "2009"
    },
    {
      "DOI": "10.1001/jama.2014.10707",
      "author": "AW Kurian",
      "doi-asserted-by": "publisher",
      "first-page": "902",
      "journal-title": "JAMA",
      "key": "1944_CR28",
      "unstructured": "Kurian AW, Lichtensztajn DY, Keegan TH, Nelson DO, Clarke CA, Gomez SL (2014) Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998–2011. JAMA 312:902–914",
      "volume": "312",
      "year": "2014"
    },
    {
      "DOI": "10.1001/jamaoncol.2018.0644",
      "author": "AW Kurian",
      "doi-asserted-by": "publisher",
      "journal-title": "JAMA Oncol",
      "key": "1944_CR29",
      "unstructured": "Kurian AW, Ward KC, Hamilton AS et al (2018) Uptake, results and outcomes of germline multiple-gene sequencing after diagnosis of breast cancer. JAMA Oncol. \n                    https://doi.org/10.1001/jamaoncol.2018.0644",
      "year": "2018"
    },
    {
      "DOI": "10.1016/S1470-2045(15)00188-6",
      "author": "C Tourneau Le",
      "doi-asserted-by": "publisher",
      "first-page": "1324",
      "journal-title": "Lancet Oncol",
      "key": "1944_CR30",
      "unstructured": "Le Tourneau C, Delord JP, Gonçalves A et al (2015) Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial. Lancet Oncol 16:1324–1334",
      "volume": "16",
      "year": "2015"
    },
    {
      "DOI": "10.1586/14737140.2015.1090879",
      "author": "J Lerner-Ellis",
      "doi-asserted-by": "publisher",
      "first-page": "1315",
      "journal-title": "Expert Rev Anticancer Ther",
      "key": "1944_CR31",
      "unstructured": "Lerner-Ellis J, Khalouei S, Sopik V, Narod SA (2015) Genetic risk assessment and prevention: the role of genetic testing panels in breast cancer. Expert Rev Anticancer Ther 15:1315–1326",
      "volume": "15",
      "year": "2015"
    },
    {
      "DOI": "10.1093/jnci/dju420",
      "author": "E Levy-Lahad",
      "doi-asserted-by": "publisher",
      "first-page": "420",
      "journal-title": "J Natl Cancer Inst",
      "key": "1944_CR32",
      "unstructured": "Levy-Lahad E, Lahad A, King MC (2014) Precision medicine meets public health: population screening for BRCA1 and BRCA2. J Natl Cancer Inst 107:420",
      "volume": "107",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s10549-017-4332-3",
      "author": "A Liede",
      "doi-asserted-by": "publisher",
      "first-page": "433",
      "journal-title": "Breast Cancer Res Treat",
      "key": "1944_CR33",
      "unstructured": "Liede A, Mansfield CA, Metcalfe KA et al (2017) Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment. Breast Cancer Res Treat 165:433–444",
      "volume": "165",
      "year": "2017"
    },
    {
      "DOI": "10.1245/s10434-014-4108-5",
      "author": "YR Liu",
      "doi-asserted-by": "publisher",
      "first-page": "1102",
      "journal-title": "Ann Surg Oncol",
      "key": "1944_CR34",
      "unstructured": "Liu YR, Jiang YZ, Yu KD, Shao ZM et al (2015) Different patterns in the prognostic value of age for breast cancer-specific mortality depending on hormone receptor status: a SEER population-based analysis. Ann Surg Oncol 22:1102–1110",
      "volume": "22",
      "year": "2015"
    },
    {
      "DOI": "10.1093/jnci/djv036",
      "author": "N Mavaddat",
      "doi-asserted-by": "publisher",
      "journal-title": "J Natl Cancer Inst",
      "key": "1944_CR35",
      "unstructured": "Mavaddat N, Pharoah PD, Michailidou K et al (2015) Prediction of breast cancer risk based on profiling with common genetic variants. J Natl Cancer Inst. \n                    https://doi.org/10.1093/jnci/djv036",
      "year": "2015"
    },
    {
      "DOI": "10.1111/cge.12865",
      "author": "J Menkiszak",
      "doi-asserted-by": "publisher",
      "first-page": "322",
      "journal-title": "Clin Genet",
      "key": "1944_CR36",
      "unstructured": "Menkiszak J, Sopik V, Chudecka-Głaz A et al (2017) The impact of an expanded genetic testing program and selective oophorectomy on the incidence of ovarian cancer in West Pomerania. Clin Genet 91:322–327",
      "volume": "91",
      "year": "2017"
    },
    {
      "DOI": "10.1093/jnci/94.20.1564",
      "author": "KA Metcalfe",
      "doi-asserted-by": "publisher",
      "first-page": "1564",
      "journal-title": "J Natl Cancer Inst",
      "key": "1944_CR37",
      "unstructured": "Metcalfe KA, Narod SA (2002) Breast cancer risk perception among women who have undergone prophylactic bilateral mastectomy. J Natl Cancer Inst 94:1564–1569",
      "volume": "94",
      "year": "2002"
    },
    {
      "DOI": "10.1007/s10689-005-4215-3",
      "author": "KA Metcalfe",
      "doi-asserted-by": "publisher",
      "first-page": "97",
      "journal-title": "Fam Cancer",
      "key": "1944_CR38",
      "unstructured": "Metcalfe KA, Snyder C, Seidel J, Hanna D, Lynch HT, Narod S (2005) The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation. Fam Cancer 4:97–103",
      "volume": "4",
      "year": "2005"
    },
    {
      "DOI": "10.1002/ijc.23340",
      "author": "KA Metcalfe",
      "doi-asserted-by": "publisher",
      "first-page": "2017",
      "journal-title": "Int J Cancer",
      "key": "1944_CR39",
      "unstructured": "Metcalfe KA, Birenbaum-Carmeli D, Lubinski J et al (2008) International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. Int J Cancer 122:2017–2022",
      "volume": "122",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.ygyno.2008.10.007",
      "author": "KA Metcalfe",
      "doi-asserted-by": "publisher",
      "first-page": "68",
      "journal-title": "Gynecol Oncol",
      "key": "1944_CR40",
      "unstructured": "Metcalfe KA, Fan I, McLaughlin J et al (2009) Uptake of clinical genetic testing for ovarian cancer in Ontario: a population-based study. Gynecol Oncol 112:68–72",
      "volume": "112",
      "year": "2009"
    },
    {
      "DOI": "10.1200/JCO.2009.25.0712",
      "author": "KA Metcalfe",
      "doi-asserted-by": "publisher",
      "first-page": "387",
      "journal-title": "J Clin Oncol",
      "key": "1944_CR41",
      "unstructured": "Metcalfe KA, Poll A, Royer R et al (2010) Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women. J Clin Oncol 28:387–391",
      "volume": "28",
      "year": "2010"
    },
    {
      "DOI": "10.1038/nature24284",
      "author": "K Michailidou",
      "doi-asserted-by": "publisher",
      "first-page": "92",
      "journal-title": "Nature",
      "key": "1944_CR42",
      "unstructured": "Michailidou K, Lindström S, Dennis J et al (2017) Association analysis identifies 65 new breast cancer risk loci. Nature 551:92–94",
      "volume": "551",
      "year": "2017"
    },
    {
      "author": "LS Mørch",
      "first-page": "1265",
      "journal-title": "N Engl J Med",
      "key": "1944_CR43",
      "unstructured": "Mørch LS, Hannaford PC, Lidegaard Ø (2018) Contemporary hormonal contraception and the risk of breast cancer. N Engl J Med 378:1265–1266",
      "volume": "378",
      "year": "2018"
    },
    {
      "DOI": "10.1001/jamaoncol.2015.2247",
      "author": "SA Narod",
      "doi-asserted-by": "publisher",
      "first-page": "1033",
      "journal-title": "JAMA Oncol",
      "key": "1944_CR44",
      "unstructured": "Narod SA (2015) Tamoxifen chemoprevention—end of the road? JAMA Oncol 1:1033–1034",
      "volume": "1",
      "year": "2015"
    },
    {
      "DOI": "10.1007/s10549-017-4644-3",
      "author": "SA Narod",
      "doi-asserted-by": "publisher",
      "first-page": "9",
      "journal-title": "Breast Cancer Res Treat",
      "key": "1944_CR45",
      "unstructured": "Narod SA, Sopik V (2018) Is invasion a necessary step for metastases in breast cancer? Breast Cancer Res Treat 169:9–23",
      "volume": "169",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.jcpo.2015.03.002",
      "author": "SA Narod",
      "doi-asserted-by": "publisher",
      "first-page": "8",
      "journal-title": "J Cancer Policy",
      "key": "1944_CR46",
      "unstructured": "Narod SA, Iqbal J, Miller A (2015) Why have breast cancer mortality rates declined? J Cancer Policy 5:8–17",
      "volume": "5",
      "year": "2015"
    },
    {
      "author": "HD Nelson",
      "key": "1944_CR47",
      "unstructured": "Nelson HD, Cantor A, Humphrey L et al (2016) Screening for breast cancer: a systematic review to update. The 2009 U.S. Preventive Services Task Force Recommendation [Internet]. Agency for Healthcare Research and Quality, Rockville",
      "volume-title": "Screening for breast cancer: a systematic review to update. The 2009 U.S. Preventive Services Task Force Recommendation [Internet]",
      "year": "2016"
    },
    {
      "DOI": "10.1001/jamaoncol.2015.5495",
      "author": "BM Norquist",
      "doi-asserted-by": "publisher",
      "first-page": "482",
      "journal-title": "JAMA Oncol",
      "key": "1944_CR48",
      "unstructured": "Norquist BM, Harrell MI, Brady MF et al (2016) Inherited mutations in women with ovarian carcinoma. JAMA Oncol 2:482–490",
      "volume": "2",
      "year": "2016"
    },
    {
      "key": "1944_CR49",
      "unstructured": "Personalized Risk Stratification for Prevention and Early Detection of Breast Cancer [Internet]. Genome Canada (2018). \n                    https://www.genomecanada.ca/en/personalized-risk-stratification-prevention-and-early-detection-breast-cancer"
    },
    {
      "DOI": "10.1038/ng853",
      "author": "PD Pharoah",
      "doi-asserted-by": "publisher",
      "first-page": "33",
      "journal-title": "Nat Genet",
      "key": "1944_CR50",
      "unstructured": "Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA (2002) Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31:33–36",
      "volume": "31",
      "year": "2002"
    },
    {
      "DOI": "10.1200/JCO.2012.47.8313",
      "author": "KA Phillips",
      "doi-asserted-by": "publisher",
      "first-page": "3091",
      "journal-title": "J Clin Oncol",
      "key": "1944_CR51",
      "unstructured": "Phillips KA, Milne RL, Rookus MA et al (2013) Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. J Clin Oncol 31:3091–3099",
      "volume": "31",
      "year": "2013"
    },
    {
      "DOI": "10.1111/tbj.12418",
      "author": "LL Reimers",
      "doi-asserted-by": "publisher",
      "first-page": "377",
      "journal-title": "Breast J",
      "key": "1944_CR52",
      "unstructured": "Reimers LL, Sivasubramanian PS, Hershman D et al (2015) Breast cancer chemoprevention among high-risk women and those with ductal carcinoma in situ. Breast J 21:377–386",
      "volume": "21",
      "year": "2015"
    },
    {
      "DOI": "10.1200/JCO.2012.43.2013",
      "author": "AS Reiner",
      "doi-asserted-by": "publisher",
      "first-page": "433",
      "journal-title": "J Clin Oncol",
      "key": "1944_CR53",
      "unstructured": "Reiner AS, John EM, Brooks JD et al (2013) Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women’s Environmental Cancer and Radiation Epidemiology Study. J Clin Oncol 31:433–439",
      "volume": "31",
      "year": "2013"
    },
    {
      "DOI": "10.1002/jcph.765",
      "author": "KT Schmidt",
      "doi-asserted-by": "publisher",
      "first-page": "1484",
      "journal-title": "J Clin Pharmacol",
      "key": "1944_CR54",
      "unstructured": "Schmidt KT, Chau CH, Price DK, Figg WD (2016) Precision oncology medicine: the clinical relevance of patient-specific biomarkers used to optimize cancer treatment. J Clin Pharmacol 56:1484–1499",
      "volume": "56",
      "year": "2016"
    },
    {
      "DOI": "10.1093/jnci/djw290",
      "author": "Y Shieh",
      "doi-asserted-by": "publisher",
      "journal-title": "J Natl Cancer Inst",
      "key": "1944_CR55",
      "unstructured": "Shieh Y, Eklund M, Madlensky L et al (2017) Breast cancer screening in the precision medicine era: risk-based screening in a population-based trial. J Natl Cancer Inst. \n                    https://doi.org/10.1093/jnci/djw290",
      "year": "2017"
    },
    {
      "DOI": "10.1007/s10549-018-4796-9",
      "author": "V Sopik",
      "doi-asserted-by": "publisher",
      "journal-title": "Breast Cancer Res Treat",
      "key": "1944_CR56",
      "unstructured": "Sopik V, Narod SA (2018) The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer. Breast Cancer Res Treat. \n                    https://doi.org/10.1007/s10549-018-4796-9",
      "year": "2018"
    },
    {
      "key": "1944_CR57",
      "unstructured": "Stand Up To Cancer Canada—Canadian Breast Cancer Foundation Dream Team Is Announced, Just One Year After Inaugural Telecast [Internet]. Philadelphia (USA): American Association for Cancer Research (2015). \n                    http://www.aacr.org/Newsroom/Pages/News-Release-Detail.aspx?ItemID=768#.VrUoSVMrJsN"
    },
    {
      "DOI": "10.1038/nature11017",
      "author": "PJ Stephens",
      "doi-asserted-by": "publisher",
      "first-page": "400",
      "issue": "7403",
      "journal-title": "Nature",
      "key": "1944_CR58",
      "unstructured": "Stephens PJ, Tarpey PS, Davies H et al (2012) The landscape of cancer genes and mutational processes in breast cancer. Nature 486(7403):400–404",
      "volume": "486",
      "year": "2012"
    },
    {
      "DOI": "10.1186/s13073-016-0364-2",
      "author": "TL Stockley",
      "doi-asserted-by": "publisher",
      "first-page": "109",
      "journal-title": "Genome Med",
      "key": "1944_CR59",
      "unstructured": "Stockley TL, Oza AM, Berman HK et al (2016) Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial. Genome Med 8:109",
      "volume": "8",
      "year": "2016"
    },
    {
      "DOI": "10.1097/IGC.0000000000001122",
      "author": "JB Szender",
      "doi-asserted-by": "publisher",
      "first-page": "26",
      "journal-title": "Int J Gynecol Cancer",
      "key": "1944_CR60",
      "unstructured": "Szender JB, Kaur J, Clayback K, Hutton ML, Mikkelson J, Odunsi K, Dresbold C (2018) Breadth of genetic testing selected by patients at risk of hereditary breast and ovarian cancer. Int J Gynecol Cancer 28:26–33",
      "volume": "28",
      "year": "2018"
    },
    {
      "DOI": "10.1148/radiol.11110469",
      "author": "L Tabar",
      "doi-asserted-by": "publisher",
      "first-page": "658",
      "journal-title": "Radiology",
      "key": "1944_CR61",
      "unstructured": "Tabar L (2011) Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 260:658–663",
      "volume": "260",
      "year": "2011"
    },
    {
      "DOI": "10.1200/PO.17.00002",
      "author": "AM Tsimberidou",
      "doi-asserted-by": "publisher",
      "journal-title": "JCO Precis Oncol",
      "key": "1944_CR62",
      "unstructured": "Tsimberidou AM, Hong DS, Ye Y et al (2017) Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT): an MD Anderson Precision Medicine Study. JCO Precis Oncol. \n                    https://doi.org/10.1200/PO.17.00002",
      "year": "2017"
    },
    {
      "DOI": "10.1093/jnci/djt453",
      "author": "D Tsoref",
      "doi-asserted-by": "publisher",
      "first-page": "djt453",
      "journal-title": "J Natl Cancer Inst",
      "key": "1944_CR63",
      "unstructured": "Tsoref D, Panzarella T, Oza A (2014) Aspirin in prevention of ovarian cancer: are we at the tipping point? J Natl Cancer Inst 106:djt453",
      "volume": "106",
      "year": "2014"
    },
    {
      "DOI": "10.1158/2159-8290.CD-11-0184",
      "author": "N Wagle",
      "doi-asserted-by": "publisher",
      "first-page": "82",
      "issue": "1",
      "journal-title": "Cancer Discov",
      "key": "1944_CR64",
      "unstructured": "Wagle N, Berger MF, Davis MJ et al (2012) High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing. Cancer Discov 2(1):82–93",
      "volume": "2",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.ygyno.2011.01.020",
      "author": "S Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "353",
      "journal-title": "Gynecol Oncol",
      "key": "1944_CR65",
      "unstructured": "Zhang S, Royer R, Li S et al (2011) Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer. Gynecol Oncol 121:353–357",
      "volume": "121",
      "year": "2011"
    }
  ],
  "reference-count": 65,
  "references-count": 65,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s00439-018-1944-6"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Personalised medicine and population health: breast and ovarian cancer"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "137"
}